EU/3/02/116

Table of contents

About

On 21 October 2002, orphan designation (EU/3/02/116) was granted by the European Commission to Liponova GmbH, Germany, for autologous renal tumour vaccine for the treatment of renal cell carcinoma.

Key facts

Active substance
Autologous Renal Cell Tumour Vaccine
Disease / condition
Treatment of renal cell carcinoma
Date of decision
21/10/2002
Outcome
Positive
Orphan decision number
EU/3/02/116

Sponsor's contact details

LipoNova
Feodor-Lynen-STr. 23
D-30625 Hannover
Germany

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating